ArticleJournal of scleroderma and related disorders2020
The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib.
Wenxia Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
50 papers cite it
this paperpooled ittrialcites it